4.5 Article

Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

The Safety of Inpatient Health Care

David W. Bates et al.

Summary: This retrospective cohort study assessed the frequency, preventability, and severity of adverse events during hospitalization in 11 Massachusetts hospitals in 2018. Adverse drug events were the most common type of events. The study found that nearly one in four admissions had at least one adverse event, and approximately one fourth of these events were preventable. These findings highlight the importance of patient safety and the need for ongoing improvement.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Review Pharmacology & Pharmacy

Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations

Tinka Bakker et al.

Summary: This study evaluated the association between methodological choices and pDDI frequency in ICU patients and provided reporting recommendations. The analysis revealed significant heterogeneity in methodological choices and a high risk of bias in the majority of studies. High risk of bias, small sample size, and use of drug prescriptions instead of administrations were associated with a higher pDDI frequency.

JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Contextualized Drug-Drug Interaction Management Improves Clinical Utility Compared With Basic Drug-Drug Interaction Management in Hospitalized Patients

Arthur T. M. Wasylewicz et al.

Summary: This study compares the clinical utility of contextualized and basic DDI management in hospitalized patients. The results show that contextualized DDI management has higher positive predictive value and number of pharmacy interventions, and no DDIs were missed, indicating that it is able to better capture relevant alerts while reducing irrelevant DDI alerts.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Article Critical Care Medicine

Clinically relevant potential drug-drug interactions in intensive care patients: A large retrospective observational multicenter study

Tinka Bakker et al.

Summary: Potential drug-drug interactions (pDDIs) may harm ICU patients, but not all of them are clinically relevant. Tailoring clinical decision support systems to the ICU setting can reduce alert fatigue and improve medication safety.

JOURNAL OF CRITICAL CARE (2021)

Article Health Care Sciences & Services

Designing and evaluating contextualized drug-drug interaction algorithms

Eric Chou et al.

Summary: The study aims to develop, validate, and test DDI alert algorithms that utilize patient context available in electronic health records data. Synthetic health records data was used for validation and real-world hospital data was used for testing, showing the potential of the algorithms to significantly reduce alert interruptions in clinical workflow. The 8 DDI algorithms developed in the study are a step towards addressing the critical need for DDI alerts that are more specific to patient context than current commercial alerting systems.

JAMIA OPEN (2021)

Review Multidisciplinary Sciences

Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis

Tamara Natasha Gonzaga de Andrade Santos et al.

PLOS ONE (2020)

Review Pharmacology & Pharmacy

Trigger tools are as effective as non-targeted chart review for adverse drug event detection in intensive care units

Renato R. Martins et al.

SAUDI PHARMACEUTICAL JOURNAL (2018)

Article Critical Care Medicine

Drug-drug interactions in the intensive care unit: Do they really matter?

D. Vanham et al.

JOURNAL OF CRITICAL CARE (2017)

Article Multidisciplinary Sciences

Imputation of adverse drug reactions: Causality assessment in hospitals

Fabiana Rossi Varallo et al.

PLOS ONE (2017)

Article Critical Care Medicine

Clinical Practice Guideline: Safe Medication Use in the ICU

Sandra L. Kane-Gill et al.

CRITICAL CARE MEDICINE (2017)

Review Urology & Nephrology

Phenotype standardization for drug-induced kidney disease

Ravindra L. Mehta et al.

KIDNEY INTERNATIONAL (2015)

Article Pharmacology & Pharmacy

Analysis of Potential Drug-Drug Interactions in Medical Intensive Care Unit Patients

Esther V. Uijtendaal et al.

PHARMACOTHERAPY (2014)

Article Critical Care Medicine

Drug-drug interactions contributing to QT prolongation in cardiac intensive care units

Michael J. Armahizer et al.

JOURNAL OF CRITICAL CARE (2013)

Article Health Care Sciences & Services

Automated Adverse Event Detection Collaborative

David C. Stockwell et al.

Journal of Patient Safety (2013)

Letter Public, Environmental & Occupational Health

Drug-related hazardous conditions to prevent injury and defining injury is also important

Sandra L. Kane-Gill et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)

Article Urology & Nephrology

Notice

Kidney International Supplements (2012)

Article Critical Care Medicine

Developing a patient safety surveillance system to identify adverse events in the intensive care unit

David C. Stockwell et al.

CRITICAL CARE MEDICINE (2010)

Article Health Care Sciences & Services

Incidence of medication errors and adverse drug events in the ICU: a systematic review

Amanda Wilmer et al.

QUALITY & SAFETY IN HEALTH CARE (2010)

Article Health Care Sciences & Services

Towards an International Classification for Patient Safety: key concepts and terms

William Runciman et al.

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2009)

Editorial Material Medicine, General & Internal

Making a difference - Adverse drug reactions in elderly people - A substantial cause of preventable illness

Jerry Avorn et al.

BRITISH MEDICAL JOURNAL (2008)

Article Pharmacology & Pharmacy

Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit

Sandra Kane-Gill et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)

Article Health Care Sciences & Services

Methodology and rationale for the measurement of harm with trigger tools

RK Resar et al.

QUALITY & SAFETY IN HEALTH CARE (2003)